Sign In
Buy APGE
Apogee Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -95.09. In total, the insiders bought 549.89K and sold 2.24M APGE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-95.09 |
| ● Buy | 549.89K shares |
| ● Sell | 2.24M shares |
|
25% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 13, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
18 659 Value: $1.53M |
||
|
May 06, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
4 125 Value: $94.3K |
||
|
May 06, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
1 800 Value: $152.3K |
||
|
May 06, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
3 700 Value: $310.5K |
||
|
May 06, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
4 125 Value: $94.3K |
||
|
May 01, 2026 Sell |
Henderson Jane Chief Financial Officer |
289 Value: $24.0K |
||
|
May 01, 2026 Sell |
Henderson Jane Chief Financial Officer |
900 Value: $74.3K |
||
|
May 01, 2026 Sell |
Henderson Jane Chief Financial Officer |
811 Value: $65.7K |
||
|
Apr 16, 2026 Buy |
Henderson Michael Thomas Chief Executive Officer |
3 000 Value: $68.6K |
||
|
Apr 16, 2026 Buy |
Henderson Michael Thomas Chief Executive Officer |
3 000 Value: $68.6K |
||
|
Apr 16, 2026 Sell |
Henderson Jane Chief Financial Officer |
2 000 Value: $180.0K |
||
|
Apr 08, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
200 Value: $17.0K |
||
|
Apr 08, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
2 000 Value: $166.5K |
||
|
Apr 08, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
17 800 Value: $1.47M |
||
|
Apr 01, 2026 Sell |
Henderson Jane Chief Financial Officer |
1 100 Value: $94.0K |
||
|
Apr 01, 2026 Sell |
Henderson Jane Chief Financial Officer |
900 Value: $76.0K |
||
|
Apr 01, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
4 125 Value: $94.3K |
||
|
Apr 01, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
100 Value: $9K |
||
|
Apr 01, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
2 702 Value: $230.6K |
||
|
Apr 01, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
2 698 Value: $227.5K |
||
|
Apr 01, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
4 125 Value: $94.3K |
||
|
Mar 25, 2026 Sell |
Henderson Jane Chief Financial Officer |
2 000 Value: $170.0K |
||
|
Mar 11, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
3 418 Value: $259.3K |
||
|
Mar 11, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
8 219 Value: $615.0K |
||
|
Mar 11, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
8 363 Value: $621.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
